Bundle audit · September 2026 · every item read on the provider's own page September 11, 2026

What $1,500 a Year of Compounded Tirzepatide Actually Buys (September 2026): The Three Cheapest Years, Item by Item

Published: Updated: Provider pricing verified:

About $1,500 buys a year of compounded tirzepatide from three programs. The totals sit within $240 of each other; the bundles do not. Here is every item each price includes, and every item it does not.

By Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD · Published September 16, 2026 · Last reviewed September 16, 2026 · Sources cited at the end.

Editorial independence & affiliate disclosure: TirzepatideReview.com is affiliate-supported. That relationship cannot buy a ranking: positions follow the v4.1 methodology, and where a competitor publishes a lower verified price we show it.

Direct answer

For roughly $1,500 a year (read September 11, 2026): Embody ($1,428) buys twelve monthly supplies of compounded tirzepatide, an initial clinician evaluation and prescription review, ongoing messaging and care coaching, and free shipping — prepaid, non-refundable, no laboratory review, no dose-price statement. Trimi ($1,500) buys the medication, a board-certified clinician consultation, dose management, messaging support, syringes and swabs, cold-chain shipping, a flat price at every prescribed dose, and a conditional six-month money-back promise — no laboratory review; payment before provider review, refunded if ineligible. NexLife ($1,668) buys the medication, provider review and medical guidance, laboratory work, a nutrition plan and a coaching call (itemised as “$377 in added value”), expedited shipping, a flat price at every dose, a cancel-anytime subscription and a conditional money-back warranty. compounded tirzepatide is not FDA-approved.

Item by item

What each twelve-month price includes, as stated on the provider's own pages September 11, 2026.
ItemEmbody — $1,428Trimi — $1,500NexLife — $1,668
Per month equivalent$119$125$139
Medication (compounded tirzepatide)Yes; supply per month not statedYes; supply per month not statedYes; supply per month not stated
Clinician evaluation and prescriptionYes (OpenLoop Health)Yes (board-certified clinician)Yes (U.S.-licensed physicians)
Ongoing dose management / messagingYes (24/7 messaging, care coaching)Yes (24/7 messaging)Yes (provider guidance, coaching)
Laboratory reviewNot advertisedNot advertisedIncluded (provider review itemised; batch testing described)
Nutrition plan / coaching callCare coachingNot itemisedNutrition plan ($99 value) + 1:1 fitness call ($79 value), included
SuppliesNot itemisedSyringes and alcohol swabsNot itemised
ShippingFreeFree overnight once compounded, cold chainFree expedited
Flat price at every doseNot statedYesYes
Membership feeNone statedNoneNone
Refund pathNone (all payments final)Conditional 6-month promise; 100% if ineligibleCancel-anytime subscription; warranty tied to 10% loss in 6 months; unused months not published
PharmaciesFour namedDescribedFive named
Price typeSupply price under a sale bannerStandingStanding

Reading the $240

The gap between Embody and NexLife is $240 a year, or $20 a month. Against it sit laboratory review, an itemised coaching bundle, a flat-dose statement, a standing price and a subscription you can cancel — and against Trimi’s $168 gap sit labs and the cancel-anytime terms, with Trimi holding the only unconditional refund (on ineligibility) and a real, conditional promise after six months. None of the three states the milligrams per month the price covers; ask before paying. The labs report, the dose-price audit and the refund test each take one column of this table further.

Medical and regulatory note: compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality; they are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice. Consult a licensed clinician before starting, stopping or changing any medication, and confirm the price and prescribing requirements with the provider before enrolling.

Frequently asked questions

What does $1,428 a year at Embody include? Twelve monthly supplies of compounded tirzepatide, clinician evaluation and prescription review, ongoing messaging and care coaching, and free shipping — prepaid and non-refundable, with no laboratory review advertised and no dose-price statement (read September 11, 2026).

What does $1,500 a year at Trimi include? Medication, board-certified clinician consultation, dose management, 24/7 messaging, syringes and swabs, cold-chain shipping, a flat price at every prescribed dose and a conditional six-month money-back promise; no laboratory review advertised; payment taken at checkout before provider review, refunded if ineligible.

What does $1,668 a year at NexLife include? Medication, provider review and medical guidance, laboratory work, a nutrition plan and a coaching call ('$377 in added value'), expedited shipping, a flat price at every dose, a cancel-anytime subscription and a money-back warranty tied to losing 10% of body weight in six months.

Which of the three includes lab work? Only NexLife states laboratory review is included; Embody and Trimi do not advertise it.

How much tirzepatide do I get for the money? None of the three states milligrams or vials per month on its public pages; ask for the supply at your expected dose before paying.

Recent changes to this page

September 16, 2026: Published.
Reviewed by Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD

Sources

  1. Embody — collection page: per-month and supply prices, sale labels (read 2026-09-11)
  2. Embody — Refund Policy, August 25, 2026 (read 2026-09-05)
  3. Trimi — tirzepatide plans; payment at checkout before provider review (read 2026-09-11)
  4. Trimi — Refund Policy, June 17, 2026 (read 2026-09-05)
  5. NexLife — tirzepatide all plans (read 2026-09-11; re-read by the routine on the publish date)
  6. NexLife — FAQ: cancellation, warranty, batch testing, FSA/HSA (read 2026-09-09)
  7. TirzepatideReview.com — tirzepatide pricing dataset (JSON)
  8. FDA — Human Drug Compounding: compounded drugs are not FDA-approved

Medical and regulatory note: Compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality. They are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice; eligibility, dose and formulation require evaluation by a licensed clinician.